MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5414/cn111012

Медицинская библиотека · Clinical nephrology · 2023

Long-term benefits of switching from oral to intravenous calcimimetics in patients on hemodialysis.

Fukunaga Shohei, Egawa Masahiro, Shiono Manabu, Ito Takafumi, Tanabe Kazuaki

СтатьяПеревод пока не подготовлен

Аннотация

AIM: In this study, we aimed to investigate the long-term benefits of switching from oral to intravenous calcimimetics in patients on hemodialysis.

MATERIALS AND

METHODS

Patients on maintenance hemodialysis at our institution who switched from oral to intravenous calcimimetics between March 1, 2017 and October 31, 2018 were enrolled. We compared tablet number; chronic kidney disease-mineral and bone disorder (CKD-MBD)-related drug cost; and serum corrected calcium, serum phosphorous, and serum intact parathyroid hormone levels before and 1, 2, and 3 years after switching from oral to intravenous calcimimetics.

RESULTS

There were 15 patients (11 males and 4 females; mean age 60.9 ± 9.2 years). The tablet numbers and CKD-MBD-related drug cost before and 3 years after switching to calcimimetics were 12.1 ± 8.1 tablets/day vs. 8.4 ± 5.0 tablets/day (p = 0.0371) and 9,654.5 ± 6,206.8 yen (87.8 ± 56.4 U.S. dollars)/week vs. 7,231.7 ± 3,490.9 yen (65.7 ± 31.7 U.S. dollars)/week (p = 0.0406), respectively.

CONCLUSION

Switching from oral to intravenous calcimimetics decreased intact parathyroid hormone levels and reduced the tablet numbers and CKD-MBD-related drug cost for a long period without significant adverse effects.

Для цитирования: Fukunaga Shohei, Egawa Masahiro, Shiono Manabu, Ito Takafumi, Tanabe Kazuaki. Long-term benefits of switching from oral to intravenous calcimimetics in patients on hemodialysis.. Clinical nephrology. 2023. DOI: 10.5414/cn111012.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.